Navigation Links
Dr. Charles Sanders to Become Lead Director of Epiphany Biosciences
Date:10/2/2008

SAN FRANCISCO, Oct. 2 /PRNewswire-FirstCall/ -- Epiphany Biosciences, Inc. announced today that Dr. Charles Sanders has accepted the position of Lead Director. Dr. Sanders is a highly experienced biotechnology and pharmaceutical executive, currently serving as Lead Director of Genentech. He has also served as chief executive officer of Glaxo Inc., from 1989-1994 and chairman of the board from 1992-1995. In addition, Dr. Sanders is also a member of the Boards of Directors of Vertex Pharmaceuticals, Cephalon, Inc., and Icagen, Inc.

"The Epiphany strategy of addressing long-term disease as sequelae of chronic viral infection offers a unique perspective in addressing unmet medical needs in a variety of patients. Dr. Volinsky has assembled an outstanding team and I am happy to work with them to reach their goals," reported Dr. Sanders.

"We are elated to have Dr. Sanders as our Lead Director. His extensive experience in the biotechnology industry has already helped propel Epiphany forward and we look forward to his continued input and counsel," stated Fred Volinsky, MD, the Chief Executive Officer of Epiphany Biosciences.

"Next year will be a critically important time for the company as we plan to collect data from up to four Phase 2 studies as well as continue further development of our HCV pipeline," commented Brian Murphy, MD, Chief Medical Officer of Epiphany. "Dr. Sanders' guidance will be very valuable at this pivotal time."

About Epiphany Biosciences:

Epiphany Biosciences is a privately-held company developing therapeutic products and diagnostic technologies that treat or help prevent the spread of pathogenic viruses, including varicella virus (VZV), Epstein-Barr Virus (EBV) and hepatitis C virus (HCV).

Contact:

Fred Volinsky

CEO of Epiphany Biosciences, Inc.

+1-415-765-7193


'/>"/>
SOURCE Epiphany Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Charles C. Harwood, Jr., Joins Cellectar, Inc.s Board of Directors
2. Ocular Biopharmaceutical Company Charlesson Announces $1.6MM in New Funding and Upcoming Presentations at The Association for Research in Vision and Ophthalmology
3. DaVita Announces Retirement of Former Chief Medical Officer Charles J. McAllister, M.D.
4. Dr. Charles A. Sims of California Cryobanks Family Cord Blood Services Named to National Stem Cell Advisory Council
5. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
6. Informed Medical Communications Appoints Charles T. Saldarini to Board of Directors
7. Leading Lobbying Firm Celebrates Growth and New Name: Troutman Sanders Strategies
8. Squire Sanders Stands Out in Independent Analysis of Law Firms in Europe
9. Sigma-Aldrich(R) Becomes First Life Science Company to Publish in Peer-Reviewed Video Journal JoVE
10. Sigma-Aldrich(R) Becomes First Life Science Company to Publish in PubMeds Peer-Reviewed Video Journal JoVE
11. MD Anderson Becomes a GeneGo Center of Excellence Using MetaCore for Oncology Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... Avelas Biosciences, an in vivo ... today that it has initiated a Phase 1b study ... with primary, non-recurrent breast cancer undergoing surgery. In commencing ... of Steven Chen , M.D., as vice president ... escalation study will enroll up to 39 women with ...
(Date:4/16/2015)... Switzerland , April 16, ... part of Debiopharm Group ™ , a Swiss-based ... target unmet medical needs as well as ... on the investigational compounds Debio 1143 (SMAC mimetic) ... presented at the 2015 Annual meeting of ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 Fairleigh ... Joseph V. Gulfo to become the Executive Director ... Simultaneously, FDU announced the kick-off of the Initiative ... spearheaded by Dr. Gulfo, under the Rothman Institute ... of Business) and in collaboration with FDU’s School ...
(Date:4/16/2015)... Seattle, Washington (PRWEB) April 16, 2015 ... for Applied Cancer Science and Resolution Bioscience, Inc. ... agreement to co-develop a novel, blood-based, clinic ready, ... lung cancer (NSCLC). The collaboration is the first ... ALK, RET, and ROS1 fusions in blinded plasma ...
Breaking Biology Technology:Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 3Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 3Dr. Joseph V. Gulfo Named Executive Director of Fairleigh Dickinson University’s Rothman Institute to Spearhead New Initiative for Patient-Centered Innovation (iPCI) 2Dr. Joseph V. Gulfo Named Executive Director of Fairleigh Dickinson University’s Rothman Institute to Spearhead New Initiative for Patient-Centered Innovation (iPCI) 3Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer 2Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer 3
... ... Netech Corporation, innovative leader in the manufacture of precision biomedical ... Pump Analyzer, IPA 2000. Utilizing Netech’s patent pending technology; accurate flow ... measured faster than ever before. IPA 2000 is compact and lightweight. ...
... ... Global Business Insights industry report. WellGen is developing propeirtary nutraceuticals for medical foods, a ... ... -- A newly released industry analysis highlights WellGen, Inc. as an important innovator in ...
... 17 November 2009 - Monetary gain stimulates activity in the ... known to activate an area of the brain called the ... 2010 issue of Cortex , published by ... striatum activation in volunteers performing a monetary task and found ...
Cached Biology Technology:Netech Corporation Announces the Release of IPA 2000 -- Infusion Pump Analyzer for Fast and Accurate Testing of All Infusion Pumps 2WellGen Recognized as Nutraceutical “Innovator” by Global Business Insights 2WellGen Recognized as Nutraceutical “Innovator” by Global Business Insights 3Monetary gain and high-risk tactics stimulate activity in the brain 2
(Date:4/13/2015)... According to a recently ... & Opportunities, 2020", the global biometrics market is ... till 2020. The biometrics market is garnering attention ... review of biometric management systems. The constant development ... greater efficiency, are resulting in increasing installation of ...
(Date:4/6/2015)... Apr. 6, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... patent 62/143028 for MINIATURE, MULTI-PURPOSE ANTENNA ... NXT-ID introduces a new revolutionary method ... surrounds the use of miniature antenna modules for ...
(Date:4/1/2015)... Apr. 1, 2015  NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces the ... wallets is underway to early access pre-order customers. ... usage at retail outlets including Walmart, Target, AT&T, Dunkin, ... Wocket was accepted at all outlets and very easy ...
Breaking Biology News(10 mins):Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4
... -- The two premier plant biology journals published by the ... and The Plant Cell -- completed their ... March 9, 2011. HighWire, the online hosting platform for more ... bottom up, creating a standards-based hosting solution that is putting ...
... energy through the process of photosynthesis, using sunlight to produce ... the transport of sugars to build different parts of the ... $6.6 million grant from the National Science Foundation to lead ... movement of carbohydrates in corn. This research may lead ...
... revolutionary type of personal power pack now in development ... the battlefield. With the aim of being up ... packs used by British infantry, the solar and thermoelectric-powered ... operations. The project is being developed by ...
Cached Biology News:ASPB journals migrate to new Web platform 2MU researcher leads new $6.6 million study that could lead to better corn plants 2Solar power systems could lighten the load for British soldiers 2Solar power systems could lighten the load for British soldiers 3
PMM2 Immunogen: PMM2 (NP_000294, 47 a.a. ~ 112 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
HOXC11 Antibody...
Rabbit polyclonal to Raf1 ( Abpromise for all tested applications). entrezGeneID: 5894 SwissProtID: P04049...
Sheep polyclonal to hCG beta core fragment ( Abpromise for all tested applications). Antigen: Full length native protein (purified) from human urine. Entrez GeneID: 1082 Swiss Protein ID...
Biology Products: